Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

7 Stocks to Avoid Due to Pandemic Worker Shortages

By Will Ashworth, InvestorPlace Contributor
Summer camps face labor shortages this summer. They aren't the only ones. Here are seven companies' stocks to avoid due to the pandemic. 

Tilray Stock Will Keep Disappointing With Poor Numbers and No Catalysts

By Faizan Farooque, InvestorPlace Contributor
In the last few months, there was no news bigger than the TLRY-APHA merger. But even after the tie-up, TLRY stock is not a winner.

7 Bubble Stocks To Sell While You Still Can

By Chris Markoch, InvestorPlace Contributor
Like a good gardener, investors should take care to prune their positions in overvalued stocks. Here are seven bubble stocks that look overvalued and ripe for selling.

BlackBerry Stock Was Interesting for a Moment

By Alex Sirois, InvestorPlace Contributor
BB stock recently got hot for the second time in 2021. Retail traders have largely abandoned it, and it's not worth buying now.

QuantumScape Stock Demands Too Great a Leap of Faith From Investors

By Josh Enomoto, InvestorPlace Contributor
QS stock has the potential to be a paradigm-shattering investment but the road to success is replete with obstacles.

Sycophantic Investors Keep Admiring Naked Stock’s New Clothes

By Chris Markoch, InvestorPlace Contributor
Bullish investors can say what they like about NAKD stock, but no amount of compliments will convince me this stock isn't naked.

This Pivot to Copper Is Unlikely to Revive the Prospects for Northern Dynasty

By Ian Bezek, InvestorPlace Contributor
After having its mine permit shot down, Northern Dynasty is trying a new approach based on green energy. But NAK stock is still risky at best.

Clover Health Investments Will Likely Give Up More Ground Before It Approaches $10

By Will Ashworth, InvestorPlace Contributor
Clover Health continues to trade below its $10 IPO price. I’ve got 35,000 reasons not to buy CLOV stock at current prices.

Why AT&T’s WarnerMedia Deal Bodes Badly for Disney Stock

By Larry Ramer, InvestorPlace Contributor
AT&T's apparent pessimism about the future of WarnerMedia spells trouble for DIS stock. Investors should sell Disney's shares.

Sell RIDE Stock After Ugly Earnings Mix and Soaring Costs

By Chris Lau, InvestorPlace Contributor
Lordstown has limited upside appeal as mounting costs outweigh the long-term revenue potential from an increasingly crowded EV market.

Sell QuantumScape Stock at Any Opportunity

By Chris Lau, InvestorPlace Contributor
QuantumScape's spending is rising and on an unsustainable path. Investors should sell QS stock as soon as it starts to rally.

Virgin Galactic Shares Can Go Where Few Have Gone Before

By Nicolas Chahine, InvestorPlace Contributor
SPCE stock has the potential to soar into the stratosphere at the drop of a hat. But it will need fundamental progress to stay there.

Oatly Has No Clear Path To Profitability At This Stage

By Muslim Farooque, InvestorPlace Contributor
OTLY stock has an enormous growth runway, but its rocky road to profitability makes its bear case more compelling at this time.

The Same Problems Persist for Ocugen in Marketing Covaxin

By Alex Sirois, InvestorPlace Contributor
OCGN stock is attempting an upward move on unrealistic expectations. There is no reason to believe it can move upward long term.

FDA’s Vaccine Attitude, New Data Don’t Bode Well for Ocugen Stock

By Larry Ramer, InvestorPlace Contributor
The FDA's recent warning that it could reject some applications for EUAs from vaccine makers does not portend well for Ocugen's aspirations. OCGN stock remains an excellent name to sell short.

7 Top Stocks To Sell For June

By Joel Baglole, InvestorPlace Contributor
As we head into summer, investors should adjust their portfolios and sell under performing stocks or stocks with a bleak outlook.

Why Airbnb Stock Is Not a Good Reopening Play

By Larry Ramer, InvestorPlace Contributor
Airbnb looks poised to be boosted less by the reopening than conventional hotels, while the valuation of ABNB stock remains tremendous.

GameStop’s Fundamentals Are a Problem

By Chris Markoch, InvestorPlace Contributor
GameStop faces significant roadblocks as it pivots to focusing on e-commerce. And that makes it even harder to be a buyer of GME stock.  

After AMC Rockets Upward, Cooler Minds Will Prevail

By Alex Sirois, InvestorPlace Contributor
AMC stock had trouble, has trouble and will continue to have trouble. There is little reason to get on board.
Load More Articles